When bleeding with clinical suspicion of factor deficiency is observed, as part of the preliminary investigation, a blood sample must be sent to a laboratory to determine the activated partial thromboplastin time (aPTT) and prothrombin time (PT). This evidence concerns the gene F2 and complement factor I deficiency.